Surgical treatment of liver tumors;A májdaganatok sebészi kezelése

Orvosi Hetilap

Volumn 145, Issue 7 SUPPL. 1, 2004, Pages 387-389

  Görög, Dénes ^a,b  

^a II sz Sebeszeti Klinika   (Hungary)

^b NONE   (Hungary)

Author keywords

Liver transplantation; Liver tumor; Surgical treatment

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER THERAPY; HUMAN; LIVER TRANSPLANTATION; LIVER TUMOR; MALIGNANT NEOPLASTIC DISEASE; TREATMENT OUTCOME; LIVER CELL CARCINOMA; LIVER RESECTION; METASTASIS; REVIEW;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 18244429260     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Belghiti, J., Hiramatsu, K., Benoist, S., és mtsai:Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate actual risk of liver resection. J. Am. Coll. Surg., 2000, 191, 38-46.
2. Choti, M. A., Sitzman, J. V., Tiburi, M. F. és mtsai: Trends in long term survival following liver resection for hepatic colorectal metastases. Ann. Surg., 2002, 235, 759-766.
3. De Carlis, L., Giacomoni, A., Lauterio, A. és mtsai: Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl. Int., 2003, 16, 115-122.
4. Figueras, J. Jaurrieta, E., Valls, C. és mtsai: Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated traetment strategy. J. Am. Col. Surg., 2000, 190, 580-587.
5. Fong, Y.: Surgical therapy of hepatic colorectal metastasis. CA Cancer J. Clin., 1999, 49, 231-255.
6. Fong, Y., Sun, R. L., Jarnagin, W. és mtsa: An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann. Surg., 1999, 229, 790-800.
7. Geoghegan, J. G., Scheele, J.: Traetment of colorectal liver metastases. Br. Surg., 1999, 86, 158-169.
8. Grazi, G. L., Ercolani, G., Pierangeli, F. és mtsai: Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann. Surg., 2001, 234, 71-78.
9. Inoue, K., Makuuchi, M., Takayama, T. és mtsai: Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery, 2000, 127, 498-505.
10. Junkg, S-E., Kim, K-H., Kim, M-Y. és mtsai: Clinical characteristics and prognosis of patients with hepatoblastoma. World J. Surg., 2001, 25, 126-130.
11. Kaihara, S., Kiuchi, T., Ueda, M. és mtsai: Living-donor liver transplantation for hepatocellular carcinoma. Transplantation, 2003, 75, S37-S40.
12. Kokudo, N., Tada, K., Seki, M. és mtsai: Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am. J. Surg., 2001, 181, 153-159.
13. Lehnert, T., Knaebel, H. T., Dück, M. és mtsai: Sequential hepatic and pulmonary resections for metastatic colorectal cancer. Br., J. Surg., 1999, 86, 241-243.
14. Le Treut, Y. P., Delpero, J. R., Dousset, B. és mtsai: Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. Ann. Surg., 1997, 225, 355.
15. Margarit, C., Charco, R., Hidalgo, E. és mtsai: Liver transplantation for malignant diseases: selection and pattern of recurrence. World J. Surg., 2002, 26, 257-263.
16. Michel, J., Suc, B., Montpeyroux, F. és mtsai: Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J. Hepatol., 1997, 26, 1274-1280.
17. Nagasue, N., Ono, T., Yamanoi, A. és mtsai: Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br. J. Surg., 2001, 88, 515-522.
18. Pascher, A., Steinmüller, T., Radke, C. és mtsai: Primary and secondary hepatic manifestation of neuroendocrine tumors. Langenbeck's Arch Surg 2000, 385, 265-270.
19. Selzner, M., Morse, M. A., Vredenburgh, J. J. és mtsai: Liver metastases from breast cancer: Long-term survival after curative resection. Surgery, 2000, 127, 383-389.
20. Takano, S., Oishi, H., Kono, S. és mtsai: Retrospective analysis of type of hepatic resection for hepatocellular carcinoma. Br. J. Surg., 2000, 87, 65-70.
21. Taniguchi, H., Takahashi, T., Sawai, K. és mtsai: Comparison in survival between hepatic metastases of gastric and colorectal cancers. Hapato-Gastroeneterology 1997, 44, 897-900.
22. Tung-Ping Poon, R. Fan, S-t., Lo, C-M. és mtsai: Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann. Surg., 2001, 234, 63-70.
23. Uenishi, T., Hirohashi, K., Kuba, S. és mtsai: Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J. Surg., 2001, 25, 865-869.
24. Velázquez, R. F., Rodríguez, M., Navascués, C. A. és mtsai: Prospexctive analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology, 2003, 37, 520-527.
25. Wei, A. C., Tung-Ping Poon, R., Fan, S-T, és mtsai: Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br. J. Surg., 2003, 90, 33-41.
26. Wong, L. L.: Current status of liver transplantation for hepatocellular cancer. Am. J. Surg., 2002, 183, 309-316.
27. Wu, C. C., Yeh, D. C., Lin, M. C. és mtsai: Improving operative safety for cirrhotic liver resection. Br. J. Surg., 2001, 88, 210-215.